Patents by Inventor Kerry A. Parker

Kerry A. Parker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7091211
    Abstract: Cyclopentyl compounds of Formula (I) are modulators of chemokine receptor activity: wherein D, G, R2, R3 and R8 in Formula (I) are defined herein. The compounds, and pharmaceutically acceptable salts and individual diastereomers thereof, are useful in the treatment and prevention of HIV infection, in delaying the onset of AIDS, and in the treatment of AIDS. The compounds are also useful for treating other diseases and conditions mediated by chemokine receptors.
    Type: Grant
    Filed: July 28, 2004
    Date of Patent: August 15, 2006
    Assignee: Merck & Co., Inc.
    Inventors: Paul E. Finke, Jennifer L. Loebach, Kerry A. Parker, Christopher W. Plummer, Sander G. Mills
  • Publication number: 20050070609
    Abstract: Cyclopentyl compounds of Formula (I) are modulators of chemokine receptor activity: wherein D, G, R2, R3 and R8 in Formula (I) are defined herein. The compounds, and pharmaceutically acceptable salts and individual diastereomers thereof, are useful in the treatment and prevention of HIV infection, in delaying the onset of AIDS, and in the treatment of AIDS. The compounds are also useful for treating other diseases and conditions mediated by chemokine receptors.
    Type: Application
    Filed: July 28, 2004
    Publication date: March 31, 2005
    Inventors: Paul Finke, Jennifer Loebach, Kerry Parker, Christopher Plummer, Sander Mills
  • Patent number: D356353
    Type: Grant
    Filed: November 23, 1993
    Date of Patent: March 14, 1995
    Inventors: Glenn K. Broyles, Kerry Parker